Skip to main content

MARKETWISE INC

For the period ended Dec 31, 2024. Filed Mar 6, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 6, 2025

MKTW$22.38+4.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.

MARKETWISE, INC.
Date: March 6, 2025By:/s/ Dr. David Eifrig
Name:Dr. David Eifrig
Title:Interim Chief Executive Officer
By:/s/ Erik Mickels
Name:Erik Mickels
Title:Chief Financial Officer

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Dr. David Eifrig and Erik Mickels, and each of them, with full power to act without the other, such person’s true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign this Form 10-K and any and all amendments thereto, and to file the same, with exhibits and schedules thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing necessary or desirable to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/s/ Dr. David EifrigInterim Chief Executive Officer and Director (Principal Executive Officer)March 6, 2025
Dr. David Eifrig
/s/ Erik MickelsChief Financial Officer (Principal Financial and Accounting Officer)March 6, 2025
Erik Mickels
/s/ Porter StansberryDirectorMarch 6, 2025
Porter Stansberry
/s/ Michael PalmerDirectorMarch 6, 2025
Michael Palmer
/s/ Van SimmonsDirectorMarch 6, 2025
Van Simmons
/s/ Matthew SmithDirectorMarch 6, 2025
Matthew Smith
/s/ Glenn TongueDirectorMarch 6, 2025
Glenn Tongue
/s/ Matthew TurnerDirector and Acting Chairman of the BoardMarch 6, 2025
Matthew Turner
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.